FindTrial
Sign In

Safety, Efficacy and Acceptability of Orthokeratology to Control Myopia Progression in China: A Large Sample Based Multi-centre Retrospective (SEAC) Study

Safety, Efficacy and Acceptability of Orthokeratology to Control Myopia Progression in China: A Large Sample Based Multi-centre Retrospective (SEAC) Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORN-16008219
Enrollment
Unknown
Registered
2016-04-05
Start date
2016-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

1:Orthokeratology

Sponsors

Optometry Research Institute,Aier Eye Hospital Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Shenyang, Wuhan, Changsha, Chongqing, Chengdu, Guangzhou, Changchun Aier Eye Hospital; from Jan. 2012 to Jun. 2015; orthokeratology wearers

Exclusion criteria

Exclusion criteria: patients basic information incomplete cases

Design outcomes

Primary

MeasureTime frame
eye axial length;Adverse event;Acceptability;—

Countries

China

Contacts

Public ContactYang Zhi kuan

Aier School of Ophthalmology, Central South University

13380071988@189.cn+86 13380071988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026